Blog

Consumer Alert: The U.S. Food & Drug Administration (FDA) has confirmed that at least 21 people have developed a life-threatening condition known as acute phosphate nephropathy after using oral sodium phosphate (OSP) medications like Visicol®. If you or a loved one has been injured by Visicol or other oral sodium phosphate medication, you should…

Gilenya (generic: fingolimod) is a prescription medication intended to treat relapsing forms of multiple sclerosis (MS) in adults. While not a cure for MS, Gilenya may prove successful in reducing subsequent flare-ups and physical deterioration. However, the introduction of Gilenya may result in catastrophic complications. Patients who receive Gilenya treatment may significantly increase their…